CJC-1295 (Without DAC) 5mg + Ipamorelin (IPA)

CJC-1295 (Without DAC) 5mg + Ipamorelin (IPA)

For Research Use Only. Not for Human Consumption.

CJC-1295 (Without DAC) and Ipamorelin are commonly paired in research settings to study growth hormone signaling pathways, endocrine function, and metabolic processes. This combination is frequently utilized by researchers investigating the synergistic effects of a Growth Hormone Releasing Hormone (GHRH) analog and a Growth Hormone Secretagogue (GHS).

CJC-1295 (Without DAC) is designed for shorter-duration activity compared to DAC-modified versions, while Ipamorelin is researched for its selective stimulation of growth hormone release pathways.

Researchers have explored this combination for studies involving:

• Growth hormone secretion pathways
• IGF-1 signaling research
• Endocrine and metabolic function
• Recovery and tissue regeneration models
• Body composition research
• Healthy aging and longevity investigations
• Sleep and circadian rhythm studies

This product contains 5mg of CJC-1295 (Without DAC) combined with Ipamorelin in a lyophilized powder form and is manufactured to high purity standards for laboratory research applications.

Product Specifications

• Compound: CJC-1295 (Without DAC) + Ipamorelin
• Strength: 5mg CJC-1295 (Without DAC) + Ipamorelin
• Form: Lyophilized Powder
• Purity: 99%+
• Storage: Store in a cool, dry environment away from direct light
• Intended Use: Research and Development Only

Quality Standards
Each batch undergoes rigorous quality control testing to ensure consistency, purity, and reliability for scientific research purposes.

Disclaimer: This product is intended exclusively for laboratory research, analytical testing, and educational purposes. It is not intended for human or veterinary use and has not been evaluated by the FDA for any medical application. Researchers are responsible for compliance with all applicable laws, regulations, and laboratory protocols.